day 1 agenda

Day -1 (Sept 20, 2022)
08:00 - 09:00 Registrations
09:00 - 09:15 Opening Ceremony & Moderator Speech
09:15- 09:45 Title: Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer
Yu Dihua,The University of Texas MD Anderson Cancer Center, USA
 
09:45- 10:15 Title: Mutant ESR1 Receptors Cooperate with the Androgen receptor to drive metastatic progression
Suzanne A. W. Fuqua, Baylor College of Medicine, USA
 
10:15- 10:45 Title: Immunological targeting of the oncogene tMUC1 leads to significant anti-tumor effects in breast cancer
Pinku Mukherjee, UNC Charlotte, USA
 
10:45 - 11:00 Group Photo & Refreshment Break
   
   
Morning Session: Breast Cancer Screening & Diagnosis
Session Chairs:
Suzanne A. W. Fuqua, Baylor College of Medicine, USA
11:00 - 11:20 Title: Quantitative Fluorescence Polarization Optical Cytology of Breast Cancer
Anna N Yaroslavsky, University of Massachusetts, USA
 
11:20 - 11:40 Title: Breast Cancer Awareness Among Afghan Refugee Women
Mutlay Sayan, Harvard University, USA
 
11:40-12:00 Title: Impact of COVID-19 and Socioeconomic Factors on Delays in High-Risk MRI Breast Cancer Screening
Helena Teng, McMaster University, Canada
 
12:00-12:20 Title: A bioinformatics analysis to investigate long non-coding RNAs mediated gene regulation in human breast invasive carcinoma
Giulia Fiscon, Sapienza University of Rome, Italy
 
12:20-12:40 Title: HER2-Low Breast Cancers: New opportunities and Challenges
Huina Zhang, University of Rochester Medical Center, USA
 
12:40-13:00 Title: Minimal Invasive Complete Duct Excision With Ultrasound-Guided Vacuum-Assisted Breast Biopsy: A Novel Technique For Pathological Nipple Discharge
Yinguang GAO, Capital Medical University, China
13:00-14:00 Lunch Break
 
Session: Breast Caner Research & Treatment
 
Session Chairs:
Huina Zhang, University of Rochester Medical Center, USA
Charles V. Clevenger, 
14:00-14:20 Title: Novel pathogenic variants in PALB2 and BARD1 genes that associated with ER+ breast cancer in Saudi Population 
Yousef MohammedRabaa Hawsawi, King Faisal Specialist Hospital and Research Centre, saudi arabia
 
14:20 - 14:40 Title: IN SILICO RECOGNITION OF A PROGNOSTIC SIGNATURE IN BASAL-LIKE BREAST CANCER PATIENTS
Federica Conte, IASI-CNR of Rome, Italy
 
14:40 - 15:00 Title: p38g integrates metabolic and immune signaling in breast tumorigenesis
Chen Guan, Medical College of Wisconsin, USA
 
15:00-15:20 Title: Prevention of breast cancer relapses by oxidizing drugs and microRNA modulation
Alberto Izzott, University of Genoa, Italy
 
15:20-15:40 Title: Antibiotic prophylaxis in breast surgery: a meta-analysis to identify the optimal strategy to reduce infection rates in breast surgery
Bader Nawaf Alali, Mubarak Al Kabeer Hospital, Ministry of Health, kuwait
 
15:40-16:00 Title: Hormonally-dependent gene expression involving the Stat5a/HDAC6/HMGN2 complex undergoes dynamic regulation and is exploitable in ER+ breast cancer
Charles V. Clevenger,  Virginia Commonwealth University, USA
 
16:00-16:10 Refreshment Break
 
16:10-16:30 Title: New therapeutic approaches in the treatment of triple-negative breast cancer
Krisztina Kovacs, University of Pécs, Hungary
 
16:30-16:50 Title: Cancer biomarker in white blood cells – An enlighten technology for cancer screening
Charoenchai P., Chulalongkorn University, Thailand
 
16:50-17:10 Title: Metastatic Breast Cancer Presenting as Pulmonary Nodules and Right Axillary Lymph Node in a Male with Chronic Lymphocytic Leukemia
Jose Maria Acostamadiedo, University of Vermont, USA
 
17:10-17:20 Title: Achillea fragrantissima (Forssk.) Sch.Bip flower dichloromethane extract exerts anti-proliferative and pro-apoptotic properties in human triple-negative breast cancer (MDA-MB-231) cells In vitro and in silico
Zeyad Ibrahim Alehaideb, King Abdullah International Medical Research Centre, Saudi Arabia
   
17:20-17:30 Title: An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy
Pasquale Sibilio, Sapienza University of Rome, Italy
  Day 1 Concludes

day 2 agenda

Day-2 (Sep-21, 2022)
Virtual Presentations
 
08:00-08:20 Title: Gene dosage analysis on the single-cell transcriptomes linking cotranslational protein targeting to metastatic triple-negative breast cancer
Min Zhao, University of the Sunshine Coast, Australia
 
08:20-08:40 Title: Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in patients with breast cancer: Clinical advances and controversies
Junyuan Lv, The Affiliated Hospital of Zunyi Medical University, China
 
08:40-09:00 Title: Mining immune-related genes with prognosticvalue in the tumor microenvironment of breastinvasive ductal carcinoma
Qiang He, Medical University, China
 
09:00-9:20 Title: Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer:A Single-Institutional Retrospective Analysis from China
Shuang-long Cai , Provincial Clinical Medical College of Fujian Medical University, China
 
09:20-09:40 Title: A cooperation of CCR7 and CXCR4 ligand chemokines regulate breast cancer cell invasion and migration toward lymphatic vessels
Haruko Hayasaka, Kindai University, Japan
 
09:40-10:00 Title: Spatially-resolved laser-activated cell sorting for breast cancer biomarker discovery
Amos Chungwon Lee, Seoul National University, south korea
 
10:00-10:20 Title: Adding features from Mathematical model of breast cancer to improve the Algorithms of machine learning
OPhir Nave, Jerusalem College of Technology, Israel
 
10:20-10:40 Title: A review of the endocrine resistance in hormone-positive breast cancer
Tsai-Ju Chien, National Yang-Ming Chiao Tung University, Taiwan
 
10:40-11:00 Title: Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
Ioannis Karampinis, University of Mainz, Germany
 
11:00-11:20 Title: Impact of doxorubicin on cell-substrate topology
Herbert Schneckenburger, Aalen University, Germany
 
11:20-11:40 Title: Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein
Joanna Kopecka, University of Turin, Italy 
 
11:40-12:00 Title: SWIM: a network-based approach for human diseases
Paola Paci, Sapienza University of Rome, Italy
 
12:00-12:20 Title: Breast cancer stem cell antigens as targets for immunotherapy and targeted therapies
Laura Conti, University of Turin, Italy 
 
12:20-12:40 Title: Preimplantation Genetic Testing for breast cancer
Oladapo, Medical Art Center Clinic, Nigeria
 
12:40-13:00 Title: Transcription and translation regulation work together during a luminal to basal transition of breast cancer cells 
Tamara Fernández-Calero, Universidad Católica del Uruguay/ Institut Pasteur de Montevideo, Uruguay
 
13:00-13:20 Title: Targeting ectopic Hsp90 with PET enabled Hsp90 inhibitors to noninvasively detect and treat metastatic breast cancer
Timothy Haystead, Duke University, USA
 
13:20-13:40 Title: Diagnostic Utility of TRPS1 Immunohistochemistry in Primary and Metastatic Breast Carcinoma with Special Emphasis on Spindle Cell Neoplasms of the Breas
Silvat Sheikh-Fayyaz, Donald and Barbara Zucker School of Medicine, USA
 
13:40-14:00 Title: Impact of smoking cessation on survival of breast cancer patients
Kareem Seoudy, University of Virginia, USA
 
14:00-14:20 Title: Tumor-Driving EGFR/K-RAS/SIAH Pathway Activation for Risk Stratifying Patients, Quantifying Therapy Efficacy, Detecting Cancer Disparity, Forecasting Tumor Relapse, and Predicting Patient Survival in Triple-Negative Breast Cancer
Amy H. Tang , Eastern Virginia Medical School, USA
 
14:20-14:40 Title: Identification of distinct immune landscapes using multiplex immunofluorescence in paraffin tumor tissues
Edwin R. Parra, The University of Texas, USA
 
14:40-15:00 Title: Incidental Breast Findings on Chest CT Studies
Cihan Duran, UT Houston Center, USA
 
15:00-15:20 Title: Hybrid metabolic phenotype and mitochondria-nuclear crosstalk can regulate breast cancer progression
Benny Kaipparettu, Baylor College Of Medicine, USA
 
15:20-15:40 Title: .Impact of using median vs. mean in calculating ERBB2 FISH results in breast cancer
Jianli Dong, University of Texas Medical Branch, USA
 
15:40-16:00 Title: Steroid receptor co-activator complexes regulate breast cancer stem cell pathways to drive therapy resistant ER+ breast cancer
Julie Hanson Ostrander, University of Minnesota, USA
 
16:00-16:20 Title: Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK–LKB1 Signaling Axis
Richard G Pestell, Baruch S Blumberg Institute, USA
 
16:20-16:40 Title: Metabolic profiling and tracking phenotypic changes in mitochondria in cancer cells with Mitometer and the phasor approach to FLIM
Michelle Digman, University of California Irvine, USA
 
16:40-17:00 Title: Src kinase/ CUB-domain containing protein 1/ protein kinase C delta pathway is active in a subset of triple-negative breast cancers and can be targeted
Olga Razorenova, University of California, USA
 
  TBA
16:40-17:00 Closing Ceremony & Refreshment Break
Note: This is the tentative program only and the timings may be subject to change
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org
Conference Hotel: 
Hotel FrontAir Congress Barcelona,
Carrer de les Alberedes, 16, 08830
Sant Boi de Llobregat,
Barcelona, Spain

Download